H
Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
KRX:293480
Price:
13 190 KRW
-0.08%
Market Closed
Updated:
May 20, 2024
Income Statement
Earnings Waterfall
Hana Pharm Co Ltd
Hana Pharm Co Ltd
|
Revenue
|
221.6B
KRW
|
|
Cost of Revenue
|
-82.8B
KRW
|
|
Gross Profit
|
138.8B
KRW
|
|
Operating Expenses
|
-109.5B
KRW
|
|
Operating Income
|
29.2B
KRW
|
|
Other Expenses
|
-5.5B
KRW
|
|
Net Income
|
23.7B
KRW
|
Income Statement
Hana Pharm Co Ltd
Hana Pharm Co Ltd
Currency: KRW
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Revenue |
147 137
N/A
|
145 999
-1%
|
152 833
+5%
|
156 766
+3%
|
159 379
+2%
|
163 384
+3%
|
166 347
+2%
|
168 322
+1%
|
169 060
+0%
|
172 619
+2%
|
177 306
+3%
|
180 041
+2%
|
186 792
+4%
|
191 424
+2%
|
196 407
+3%
|
202 631
+3%
|
205 176
+1%
|
209 975
+2%
|
210 845
+0%
|
214 229
+2%
|
220 494
+3%
|
221 575
+0%
|
|
| Gross Profit | |||||||||||||||||||||||
| Cost of Revenue |
(47 322)
|
(45 940)
|
(50 926)
|
(52 344)
|
(53 375)
|
(54 809)
|
(56 150)
|
(57 860)
|
(58 901)
|
(61 279)
|
(63 283)
|
(63 159)
|
(64 987)
|
(65 182)
|
(65 589)
|
(69 735)
|
(72 511)
|
(77 502)
|
(79 605)
|
(81 031)
|
(82 841)
|
(82 823)
|
|
| Gross Profit |
99 815
N/A
|
100 059
+0%
|
101 907
+2%
|
104 422
+2%
|
106 005
+2%
|
108 576
+2%
|
110 197
+1%
|
110 462
+0%
|
110 157
0%
|
111 338
+1%
|
114 023
+2%
|
116 881
+3%
|
121 805
+4%
|
126 243
+4%
|
130 818
+4%
|
132 896
+2%
|
132 666
0%
|
132 473
0%
|
131 240
-1%
|
133 198
+1%
|
137 653
+3%
|
138 752
+1%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(66 538)
|
(67 256)
|
(68 344)
|
(70 509)
|
(72 978)
|
(75 356)
|
(76 631)
|
(78 017)
|
(78 596)
|
(79 336)
|
(82 348)
|
(85 957)
|
(87 182)
|
(92 810)
|
(94 808)
|
(94 520)
|
(97 570)
|
(97 914)
|
(100 069)
|
(103 120)
|
(106 264)
|
(109 507)
|
|
| Selling, General & Administrative |
(64 768)
|
(66 190)
|
(65 463)
|
(69 515)
|
(70 180)
|
(71 645)
|
(72 553)
|
(73 182)
|
(73 622)
|
(74 150)
|
(76 908)
|
(80 724)
|
(81 288)
|
(86 711)
|
(88 293)
|
(87 848)
|
(90 362)
|
(90 146)
|
(91 824)
|
(93 656)
|
(96 497)
|
(99 041)
|
|
| Research & Development |
0
|
0
|
(2 191)
|
(1 036)
|
(1 862)
|
(2 431)
|
(2 562)
|
(2 795)
|
(2 982)
|
(3 142)
|
(3 242)
|
(3 303)
|
(3 303)
|
(3 320)
|
(3 489)
|
(3 663)
|
(3 983)
|
(4 413)
|
(4 748)
|
(5 860)
|
(6 171)
|
(6 853)
|
|
| Depreciation & Amortization |
0
|
0
|
(690)
|
(478)
|
(787)
|
(1 131)
|
(1 515)
|
(1 761)
|
(1 992)
|
(2 146)
|
(2 197)
|
(2 481)
|
(2 592)
|
(2 862)
|
(3 026)
|
(3 009)
|
(3 224)
|
(3 355)
|
(3 497)
|
(3 560)
|
(3 575)
|
(3 613)
|
|
| Other Operating Expenses |
(1 770)
|
(1 066)
|
0
|
520
|
(149)
|
(149)
|
0
|
(279)
|
0
|
102
|
0
|
551
|
0
|
83
|
0
|
0
|
0
|
0
|
0
|
(44)
|
(21)
|
0
|
|
| Operating Income |
33 276
N/A
|
32 802
-1%
|
33 563
+2%
|
33 913
+1%
|
33 027
-3%
|
33 220
+1%
|
33 566
+1%
|
32 446
-3%
|
31 562
-3%
|
32 003
+1%
|
31 675
-1%
|
30 923
-2%
|
34 622
+12%
|
33 433
-3%
|
36 010
+8%
|
38 377
+7%
|
35 096
-9%
|
34 559
-2%
|
31 171
-10%
|
30 078
-4%
|
31 389
+4%
|
29 245
-7%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
(899)
|
(659)
|
100
|
1 017
|
1 791
|
2 303
|
2 101
|
1 685
|
1 476
|
1 265
|
1 131
|
1 012
|
998
|
822
|
695
|
682
|
507
|
(174)
|
(188)
|
(473)
|
(51)
|
339
|
|
| Non-Reccuring Items |
0
|
0
|
(147)
|
0
|
0
|
0
|
(279)
|
0
|
101
|
0
|
170
|
0
|
83
|
0
|
0
|
0
|
64
|
65
|
(44)
|
0
|
0
|
(32)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
41
|
0
|
16
|
38
|
37
|
53
|
62
|
166
|
544
|
544
|
839
|
982
|
27
|
20
|
(275)
|
(653)
|
(104)
|
(115)
|
(121)
|
(5)
|
|
| Total Other Income |
(1 333)
|
(1 328)
|
(1 225)
|
(1 158)
|
(323)
|
(337)
|
(563)
|
(531)
|
(786)
|
(1 064)
|
(5 025)
|
(5 353)
|
(5 339)
|
(5 939)
|
(885)
|
(996)
|
(876)
|
259
|
(116)
|
2
|
98
|
(415)
|
|
| Pre-Tax Income |
31 044
N/A
|
30 813
-1%
|
32 332
+5%
|
33 773
+4%
|
34 511
+2%
|
35 226
+2%
|
34 862
-1%
|
33 653
-3%
|
32 415
-4%
|
32 368
0%
|
28 495
-12%
|
27 125
-5%
|
31 203
+15%
|
29 299
-6%
|
35 847
+22%
|
38 082
+6%
|
34 515
-9%
|
34 055
-1%
|
30 718
-10%
|
29 492
-4%
|
31 316
+6%
|
29 132
-7%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
(6 271)
|
(6 510)
|
(6 163)
|
(6 412)
|
(5 935)
|
(5 878)
|
(6 558)
|
(6 528)
|
(7 197)
|
(6 419)
|
(13 603)
|
(13 335)
|
(13 898)
|
(12 562)
|
(7 833)
|
(8 433)
|
(7 713)
|
(9 529)
|
(6 411)
|
(5 970)
|
(5 947)
|
(5 405)
|
|
| Income from Continuing Operations |
24 773
|
24 303
|
26 169
|
27 361
|
28 575
|
29 346
|
28 304
|
27 123
|
25 218
|
25 950
|
14 893
|
13 791
|
17 305
|
16 737
|
28 014
|
29 650
|
26 802
|
24 526
|
24 307
|
23 522
|
25 369
|
23 726
|
|
| Income to Minority Interest |
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
24 775
N/A
|
24 304
-2%
|
26 170
+8%
|
27 362
+5%
|
28 576
+4%
|
29 346
+3%
|
28 304
-4%
|
27 123
-4%
|
25 218
-7%
|
25 950
+3%
|
14 893
-43%
|
13 791
-7%
|
17 305
+25%
|
16 737
-3%
|
28 014
+67%
|
29 650
+6%
|
26 802
-10%
|
24 526
-8%
|
24 307
-1%
|
23 522
-3%
|
25 369
+8%
|
23 726
-6%
|
|
| EPS (Diluted) |
1 769.64
N/A
|
1 736
-2%
|
1 744.66
+0%
|
1 520.11
-13%
|
1 587.55
+4%
|
1 726.23
+9%
|
1 572.44
-9%
|
1 595.47
+1%
|
1 483.41
-7%
|
1 526.47
+3%
|
860.74
-44%
|
797.06
-7%
|
1 056.12
+33%
|
967.48
-8%
|
1 679.05
+74%
|
1 713.9
+2%
|
1 549.28
-10%
|
1 417.7
-8%
|
1 405.08
-1%
|
1 359.68
-3%
|
1 466.45
+8%
|
1 371.49
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
